Whistleblower Group

And Yet Another Whistleblower-Originated False Claims Act Kickback Settlement

By the Constantine Cannon Whistleblower Team Last Thursday (July 30), the Department of Justice (DOJ) announced that Houston-based Access DX Laboratory -- and its former CEO Michael Stewart along with Florida businessman Harold Shatz -- agreed to collectively pay $36.4 million to settle allegations they violated the False Claims Act and Anti-Kickback Statute by paying kickbacks and billing Medicare/Medicaid for...

Addiction Recovery Care and Affiliates Pay $16.2M Civil Judgment to Resolve Kentucky Medicaid Fraud Allegations

By the Constantine Cannon Whistleblower Team Kentucky-based Addiction Recovery Care, LLC (“ARC”), plus its affiliates Pioneer Health Group, LLC and Science Hill Family Care, LLC, agreed to pay $16,205,774 to resolve allegations that they defrauded the Kentucky Medicaid program and violated the False Claims Act, a federal statute that prohibits submissions of false claims for payment to government healthcare...

IRS Honors Whistleblowers With National Whistleblower Day Shout-Out

By the Constantine Cannon Whistleblower Team Last Tuesday (July 28), the Internal Revenue Service (IRS) provided the ultimate shout-out to whistleblowers by highlighting National Whistleblower Day “and the important role whistleblowers play in exposing fraud, reducing the tax gap, and strengthening compliance.”[1]  It follows a similar toasting of whistleblowers the IRS made on the eve of National...

Catching A COVID-19-Era Fugitive and More COVID-19-Related Fraud Enforcement Actions

By the Constantine Cannon Whistleblower Team Over the last few weeks, the government has announced a slew of COVID-19-related fraud enforcement actions. We’re diving into the recent stream of activity and what this could indicate in terms of the government’s future enforcement priorities. Several of the cases we’re reporting on were initiated by whistleblowers (or relators) under the qui tam (or...

DOJ Continues Full Court Press Against Customs Fraud and For Whistleblowers to Help the Charge

By the Constantine Cannon Whistleblower Team On July 14, the Department of Justice (DOJ) announced it had crossed the $1 billion threshold in civil and criminal customs fraud recoveries since launching its Trade Fraud Task Force last August.[1]  DOJ described it as a major milestone that “reflects a fundamental shift in the federal government’s approach to customs and trade enforcement, emphasizing rigorous...

NeoGenomics Pays $9.8M to Resolve Potential False Claims Act Violations Related to Alleged Lab Testing Kickbacks

By the Constantine Cannon Whistleblower Team On July 20, Florida-based NeoGenomics Laboratories Inc. (NeoGenomics) agreed to pay $9,813,260 to settle allegations it violated the False Claims Act by offering two types of illegal kickbacks. According to the press release announcing the settlement, NeoGenomics offered below-market consulting services to healthcare providers in exchange for patient referrals and also...

Redi-Bag Pays $7.3M in Latest Whistleblower-Originated Customs Fraud Case

By the Constantine Cannon Whistleblower Team Last Wednesday (July 15), the Department of Justice (DOJ) announced that Redi-Bag USA and its CEO, Jeffrey Rabiea, agreed to pay $7.3 million to settle allegations they violated the False Claims Act by engaging in customs fraud.[1]  Specifically, DOJ claimed the New York-based supplier of custom bags, liners, and packaging misrepresented to Customs and Border Protection...

Labcorp Settles False Claims Act Allegations of Unnecessary Urine Drug Testing for $14.5 Million

By the Constantine Cannon Whistleblower Team On July 15, the United States Attorney’s Office for the District of Massachusetts announced that Laboratory Corporation of America (Labcorp), a national diagnostic testing laboratory, agreed to pay $14.5 million to resolve allegations that it violated the False Claims Act by submitting medically unnecessary claims for urine drug testing (UDT) to Medicare. [1]

What...

SEC Files Settled Action Alleging Battle Motors and its CEO Misled Investors

By the Constantine Cannon Whistleblower Team The SEC recently filed a settled action alleging that vehicle manufacturer Battle Motors, Inc. and its CEO and Chairman, Michael W. Patterson, misled investors in connection with a convertible debt offering by overstating Battle’s performance metrics.  This case serves as another example that SEC enforcement actions are not limited to massive publicly traded...

Constantine Cannon Partner Gordon Schnell Featured in NY Post Article On the Rise in High-Tech Healthcare Fraud by Organized Crime

& the Constantine Cannon Whistleblower Team On July 13, the New York Post published an article on its investigation into the rise of healthcare fraud by foreign criminals using high-tech scams.[1]  The Post interviewed and heavily featured Constantine Cannon whistleblower partner Gordon Schnell in the piece. According to the Post’s investigation, international criminal networks are stealing confidential...